Xu Xiaofeng, Former General Manager of Roche China's Primary Care and Specialty Care Divisions, Departs to Pursue New Opportunities

Today, Roche announced that Xu Xiaofeng, General Manager of the Generics Business Unit and Specialty Care Business Unit at Roche China, will leave the company on March 31, 2021, to pursue external development opportunities due to personal reasons.

It is reported that Xu Xiaofeng joined Roche Pharmaceuticals in February 2017, serving as Vice President of Strategy Optimization and Operations, among other roles. He later assumed the position of Vice President for both the General Medicines Business Unit and the Specialty Care Business Unit, contributing to the formulation of multiple core strategies for Roche Pharmaceuticals China. Following his departure from Roche Pharmaceuticals, the Specialty Care Business Unit was temporarily overseen by Qian Wei, Vice President of Roche Oncology Business Unit 1.